CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-02 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +1,861 | 23,914 | ||
| 2024-09-02 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −956 | $26.74 | $26K | 22,958 |
| 2024-09-02 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,861 | 1,861 | ||
| 2024-09-02 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,569 | 82,728 | ||
| 2024-09-02 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −3,177 | $26.74 | $85K | 79,551 |
| 2024-09-02 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,569 | 6,569 | ||
| 2024-09-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +1,725 | 52,873 | ||
| 2024-09-02 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes 10b5-1 | −835 | $26.74 | $22K | 52,038 |
| 2024-09-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −1,725 | 1,725 | ||
| 2024-09-02 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +994 | 22,081 | ||
| 2024-09-02 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes 10b5-1 | −345 | $26.74 | $9K | 21,736 |
| 2024-09-02 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −994 | 994 | ||
| 2024-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +4,499 | 124,410 | ||
| 2024-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −1,322 | $26.74 | $35K | 123,088 |
| 2024-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Restricted Share Unit | +6,981 | 6,981 | ||
| 2024-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Share Option | +36,300 | 36,300 | ||
| 2024-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −2,726 | 5,452 | ||
| 2024-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,773 | 5,318 | ||
| 2024-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +6,490 | 28,744 | ||
| 2024-09-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −2,755 | $26.74 | $74K | 25,989 |
Page 47 of 74 · 1,467 trades